PACS goes into wild blue yonder
Agfa has received approval from the U.S. Air Force to operate its PACS technology. The company's Impax product line received a certificate of "networthiness" from the USAF by meeting guidelines defined by the Defense Information Systems Agency in
Agfa has received approval from the U.S. Air Force to operate its PACS technology. The company's Impax product line received a certificate of "networthiness" from the USAF by meeting guidelines defined by the Defense Information Systems Agency in accordance with Department of Defense regulations for IT security. Clearing those hurdles, specifically, were the Impax 4.5, the company's latest PACS; Impax Web1000, which provides secure remote access to enterprise-wide clinical images; and Agfa Mil-PACS RIS Gateway, which allows RIS and PACS technologies to communicate. The company has implemented more than $100 million in PACS and teleradiology systems at more than 75 DOD Medical Treatment Facilities worldwide, including 28 U.S. Navy warships and two U.S. Navy hospital ships.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
